Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light

Journal of Pineal Research

Volumn 36, Issue 3, 2004, Pages 177-185

  Castañeda, Tamara R ^a   Marquez De Prado, Blanca ^a   Prieto, David ^b   Mora, Francisco ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Circadian rhythm; Light; Neurotransmitters; Nucleus accumbens; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; ARGININE; CATECHOLAMINE; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; HOMOVANILLIC ACID;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORPUS STRIATUM; LIGHT DARK CYCLE; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STATISTICAL ANALYSIS;

EID: 1842557666     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-079X.2003.00114.x     Document Type: Article

References (45)

1. MOGENSON GJ, YIM CC. Neuromodulatory functions of the mesolimbic dopamine system: electrophysiological and behavioural studies. In: The Mesolimbic Dopamine System: from Motivation to Action. Willmer P, Scheel-Krüger J, eds. John Wiley and Sons, Chichester, 1991; pp. 105-130.
2. SMITH AD, OLSON RJ, JUSTICE JB, Jr. Quantitative microdialysis of dopamine in the striatum: effect of circadian variation. J Neurosci Methods 1992; 44:33-41.
3. PAULSON PE, ROBINSON TE. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 1994; 108:624-635.
4. PAULSON PE, ROBINSON TE. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Neuropsychopharmacology 1996; 14:325-337.
5. WESTERINK BHC. Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res 1995; 70: 103-124.
6. RUETER LE, JACOBS BL. Changes in forebrain serotonin at the light-dark transition: correlation with behaviour. Neuroreport 1996; 7:1107-1111.
7. DRIJFHOUT WJ, VAN DER LINDE AG, KOOI SE et al. Norepinephrine release in the rat pineal gland: the input from biological clock measured by in vivo microdialysis. J Neurochem 1996; 66:748-755.
8. MITSUSHIMA D, MIZUNO T, KIMURA F. Age-related changes in diurnal acetylcholine release in the prefrontal cortex of male rats as measured by microdialysis. Neuroscience 1996; 72: 429-434.
9. KAMETANI H, KAWAMURA H. Circadian rhythm of cortical acetylcholine release as measured by in vivo microdialysis. Neurosci Lett 1991; 132:263-266.
10. JIMENEZ-CAPDEVILLE ME, DYKES R. Daily changes in the release of acetylcholine from rat primary somatosensory cortex. Brain Res 1993; 625:152-158.
11. NICHOLLS DG. The glutamatergic nerve terminal. Eur J Biochem 1993; 212:613-631.
12. DELOREY TM, OLSEN RW. GABA and glycine. In: Basic Neurochemistry. Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds. Raven Press, New York, 1994; pp. 389-400.
13. HONMA S, KATSUNO Y, SHINOHARA K et al. Circadian rhythm and response to light of extracellular glutamate and aspartate in rat suprachiasmatic nucleus. Am J Physiol 1996; 40:579-585.
14. MILLER JD, MORIN LP, SCHWARTZ WJ, MOORE RY. New insights into the mammalian circadian clock. Sleep 1996; 19:641-667.
15. WAGNER S, CASTEL M, GAINER H, YAROM Y. GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature 1997; 387:598-603.
16. BUIJS RM, KALSBEEK A. Hypothalamic integration of central and peripheral clocks. Nat Rev 2001; 2:521-526.
17. MARQUEZ DE PRADO B, CASTAÑEDA TR, GALINDO A et al. Melatonin disrupts circadian rhythms of glutamate and GABA in the neostriatum of the awake rat: a microdialysis study. J Pineal Res 2000; 29:209-216.
18. GROENNEWENGEN HJ, BERENDSE GE, MEREDITH GE et al. Functional anatomy of the ventral, limbic system-innervated striatum. In: The Mesolimbic Dopamine System: from Motivation to Action. Willmer P, Scheel-Krüger J, eds. John Wiley and Sons, Chichester, 1991; pp. 19-60.
19. MEIJER JH, RIETVELD WJ. Neurophysiology of the suprachiasmatic circadian pacemaker in rodents. Physiol Rev 1989; 69:671-707.
20. PARSONS LH, JUSTICE JB, Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 1993; 606:195-199.
21. DE DEURWAERDERE P, SPAMPINATO U. Role of serotonin (2A) and serotonin (2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicitated in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 1999; 73:1033-1042.
22. BOWERS BJ, HENRY MB, THIELEN RJ, MC BRIDE WJ. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. J Neurochem 2000; 75:1625-1633.
23. SEGOVIA G, DEL ARCO A, MORA F. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem 1997; 69:1476-1483.
24. SEGOVIA G, DEL ARCO A, MORA F. Effects of aging on the interaction between glutamate, dopamine and GABA in striatum and nucleus accumbens of the awake rat. J Neurochem 1999; 73:2063-2072.
25. DEL ARCO A, SEGOVIA G, FUXE K, MORA F. Changes of dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J Neurochem 2003; 85:23-33.
26. KONING JRF, KLIPPEL RA. The Rat Brain. R.E. Krieger Publishing Co., New York, 1967.
27. SEGOVIA G, MORA F. Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull 1998; 45:275-279.
28. DEL ARCO A, MORA F. Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine and dopamine metabolites in the prefrontal cortex of the freely moving rat: involvement of NMDA and AMPA/kainate receptors. Neurochem Res 1999; 24:1027-1035.
29. MINORS DS, WATERHOUSE JM. Mathematical and statistical analysis of circadian rhythm. Psychoneuroendocrinology 1988; 13:443-464.
30. DIEZ-NORGUERA A, CAMBRAS T. Determinación de las características del ritmo en variables biológicas. Método del Cosinor. Inf Med Biol 1981; 3:25-30.
31. BHASKARAN D, RADHA E. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age. Exp Gerontol 1984; 19:153-170.
32. O'NEILL RD, FILLENZ M. Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: effect of drugs, circadian changes and correlations with motor activity. Neuroscience 1985; 16:49-55.
33. REFINETTI R. Environmental influences. In: Circadian Physiology. CRC Press, Boca Raton, 2000; pp. 61-76.
34. BETTAHI I, POZO D, OSUNA C et al. Melatonin reduce nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20:205-210.
35. BURLET S, CESPUGLIO R. Voltametric detection of nitric oxide (NO) in the rat brain: its variation throughout the sleep-wake cycle. Neurosci Lett 1997; 226:131-135.
36. SHIEH K-R, CHU Y-S, PAN J-T. Circadian change of dopaminergic neuron: effects of constant light and melatonin. Neuroreport 1997; 8:2283-2287.
37. SCHADE R, VICK K, OTT T et al. Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens in striatum of rats: influence on dopaminergic stimulation. Chronobiol Int 1995; 12:87-99.
38. REFINETTI R. Neurophysiology and pharmacology of the clock. In: Circadian Physiology. CRC Press, Boca Raton, 2000; pp. 99-115.
39. ROMERO L, CASANOVAS JM, HERVÁS I et al. Strategies to optimise the antidepressant action of selective serotonin reuptake inhibitors. In: Antidepressants: New Pharmacological Strategies. Skolnick R, ed. Humana Press Inc., Totowa, 1997; pp. 1-33.
40. FERRÉ S, O'CONNOR WT, SNAPRUD P et al. Antagonistic interaction between adenosine A2a receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 1994; 63: 765-773.
41. BENLOUCIF S, KEEGAN MJ, GALLOWAY MP. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 1993; 265:373-377.
42. WEST AR, GALLOWAY MP. Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms. Synapse 1996; 23:20-27.
43. SANTIAGO M, MATARREDONA ER, MACHADO A, CANO J. Influence of serotoninergic drugs on in vivo dopamine extracellular output. J Neurosci Res 1998; 52:591-598.
44. KHALDY H, LEÓN J, ESCAMES G, BIKJDAOUENE L, GARCÍA JJ, ACUÑA-CASTROVIEJO D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinol 2002; 75:201-208.
45. REITER RJ. The melatonin: both clock and calendar. Experimentia 1993; 49:654-664.